It was reported that LOXL1 was related to the progression of various tumors, such as glioma, gastric cancer, colorectal cancer, pancreatic ductal adenocarcinoma (PDAC) [55]. This evidence concerns the gene LOXL1 and pancreatic ductal adenocarcinoma.